Please select a Capability in order to start your service request.
Marks Fifth Year Finishing in Top Spot for Infection Control and Monitoring CategoryFeb 26, 2015
February 26, 2015 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced that MedMined® Surveillance Advisor has once again finished first in a KLAS report for Infection Control and Monitoring.
This award marks the fifth year that MedMined Surveillance Advisor has been recognized as the leader for Infection Control and Monitoring by KLAS, an organization that independently monitors health care information technology performance through the active participation of thousands of health care organizations.
“We are honored that hospitals and infection control professionals have once again ranked MedMined Surveillance Advisor as the best technology for Infection Control and Monitoring,” said Bert Williams, vice president and general manager of MedMined Services for CareFusion. “Our proprietary technology and methodology not only help clinicians identify areas for improvement, but the infection data is tied to data from the hospital’s financial systems to show the true costs of every infection across the system.”
MedMined Surveillance Advisor provides automated infection surveillance proven to help hospitals identify and reduce health care associated infections (HAIs)—ultimately facilitating hospitals' efforts to save lives and reduce costs. The proprietary tool uses a proxy marker to identify potential HAIs, while algorithms automatically detect clinically meaningful patterns in complex data sets, similar to the data mining technology used by credit card companies to detect fraud. By placing the right information in the right hands at the right time, the infection prevention team is empowered to efficiently focus resources on emerging trends in HAIs and multiple-drug resistant organisms. This refined approach to electronic surveillance allows for more time to be spent on clinical intervention and education.
MedMined Surveillance Advisor has been studied and published in numerous peer-reviewed publications, as well as financially peer-reviewed receiving the Healthcare Financial Management Association Peer Review designation.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.